Joseph Papa, chairman and CEO of Perrigo, said: “The acquisition of Laboratorios Diba will enable us to market an additional 150 formulas and 50 trademarks into the rapidly growing Mexican store brand market, saving consumers money on their healthcare options. This further exemplifies Perrigo’s commitment to meeting the growing need for quality, affordable healthcare around the world.”